In NSCLC cells, the importance of EGFR, another RTK, localized in the nucleus has been confirmed in the development of resistance to cetuximab, suggesting that FGFRs nucleocytoplasmic transport may also contribute to the development of drug resistance [134]. Here, EGFR is linked to non-small cell lung carcinoma.